Pancreatic Cancer Research

ResearcherSichuan UniversityActive in the last 2 years

Ang Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-5261-7577; OpenAlex author ID A5100664194. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
7
Papers, trials and grants by year

2020: 1 paper · 2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper · 2025: none · 2026: 1 paper

Papers 4

  1. Plasma Proteomic Profiling Identifies Candidate Biomarkers for Pancreatic Ductal Adenocarcinoma. Last author DOI 10.1002/jcla.70313↗
  2. Quantitative site-specific N-glycosylation analysis reveals IgG glyco-signatures for pancreatic cancer diagnosis. Co-author DOI 10.1186/s12014-024-09522-4↗
  3. Symptom evaluation in pancreatic cancer detection. Co-author DOI 10.1016/j.asjsur.2021.08.028↗
  4. Integrated epigenetic biomarkers in circulating cell-free DNA as a robust classifier for pancreatic cancer. Last author DOI 10.1186/s13148-020-00898-2↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yi Jin · 2 shared papers, 2024–2026 · strength 0.61
  2. Yong Zhang · 2 shared papers, 2024–2026 · strength 0.61
  3. Ailin Wei · 3 shared papers, 2020–2024 · strength 0.55
  4. Lelang Xiang · 1 shared paper, 2026 · strength 0.36
  5. Jue Yuan · 2 shared papers, 2020–2021 · strength 0.29
  6. Mei Rosemary Fu · 1 shared paper, 2021 · strength 0.19
  7. Feng Cao · 1 shared paper, 2020 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.